Catalysts / PYPD
Upcoming FDA decisions and readouts we track for PolyPid Ltd., each with the filing that announced it.
FreeBioList tracks 1 upcoming catalyst for PolyPid Ltd. (PYPD, listed on Nasdaq). It concerns D-PLEX100 (Prevention of surgical site infection in abdominal colorectal surgery).
First on the list: the PDUFA date for D-PLEX100 (Prevention of surgical site infection in abdominal colorectal surgery), dated 28 Nov 2026.
The row links to an SEC filing (8-K or 6-K). It has been verified by a person reading the filing itself, most recently on 11 Sep 2026. The methodology page explains each status.
Background reading: What a PDUFA date is, and why the FDA doesn't publish them.
| Company ▾ | Drug ▾ | Effect / indication | Next catalyst ▾ | Phase / type ▾ | Status ▾ | Source | Options |
|---|---|---|---|---|---|---|---|
| PolyPid Ltd. PYPD · Nasdaq | D-PLEX100 | Prevention of surgical site infection in abdominal colorectal surgery | 28 Nov 2026 in 52d |
PDUFA date | Verified | 6-K exhibit 99.1 ↗ | Yes |
FreeBioList